Filing Flows › MiniMed Group (MMED) › Q1 2026 › vs Q1 2026
MiniMed Group (MMED) Q1 2026 vs Q1 2026 (quarter over quarter)
MiniMed Group's revenue rose $47.0M (+6%) from $790M in Q1 2026 to $837M in Q1 2026. The biggest changes: CGM +$30.0M (+8%); Other +$17.0M (+340%); Pumps −$6.0M (-4%).
MiniMed Group, Q1 2026: revenue $837M (+16% year over year), operating margin -11.1%, net loss $185M, operating cash flow −$170M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| CGM | $420M | $390M | $30.0M | +8% |
| Consumables | $249M | $244M | $5.0M | +2% |
| Pumps | $145M | $151M | −$6.0M | -4% |
| Other | $22.0M | $5.0M | $17.0M | +340% |
| Revenue | $837M | $790M | $47.0M | +6% |
| Net loss | $185M | $111M | $74.0M | +67% |
| Costs & expenses | $1.0B | $902M | $121M | +13% |
| Operating costs | $930M | $890M | $40.0M | +4% |
| Income tax | $93.0M | $12.0M | $81.0M | +675% |
| Cost of revenue | $357M | $428M | −$71.0M | -17% |
| Research & development | $99.0M | $114M | −$15.0M | -13% |
| SG&A | $299M | $309M | −$10.0M | -3% |
| Other operating costs | $175M | $39.0M | $136M | +349% |
| Depreciation & amortization | $39.0M | $0 | $39.0M | — |
| Share-based compensation | $8.0M | $11.0M | −$3.0M | -27% |
| Net loss absorbed | $185M | $111M | $74.0M | +67% |
Questions
How much did MiniMed Group's revenue grow quarter over quarter in Q1 2026?
MiniMed Group's revenue rose $47.0M (+6%) from $790M in Q1 2026 to $837M in Q1 2026.
What drove MiniMed Group's revenue change in Q1 2026?
CGM +$30.0M (+8%); Other +$17.0M (+340%); Pumps −$6.0M (-4%).